Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 8/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.57 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.57 |
| ▸ | FABP3 | P05413 | 1/20 | 0.57 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.54 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.54 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.54 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1402383 | 1.00 | ENPP2 (0.59) | ENPP2LPAR3LPAR1SMN1; SMN2PLA2G2C | |
| SCHEMBL6254776 | 0.94 | PRKCA (0.56) | ENPP2LPAR3LPAR1SMN1; SMN2FABP3 | |
| SCHEMBL7204294 | 0.94 | PRKCA (0.56) | ENPP2LPAR3LPAR1SMN1; SMN2FABP3 | |
| SCHEMBL14659956 | 0.94 | PRKCA (0.56) | ENPP2LPAR3LPAR1SMN1; SMN2FABP3 | |
| SCHEMBL19629017 | 0.94 | ENPP2 (0.57) | ENPP2LPAR3LPAR1SMN1; SMN2FABP3 | |
| SCHEMBL16714278 | 0.93 | ENPP2 (0.64) | ENPP2LPAR3LPAR1 | |
| SCHEMBL190727 | 0.93 | ENPP2 (0.64) | ENPP2LPAR3LPAR1 | |
| SCHEMBL18719361 | 0.91 | ENPP2 (0.63) | ENPP2LPAR3LPAR1SMN1; SMN2FABP3 | |
| SCHEMBL2126025 | 0.88 | PRKCE (0.61) | ENPP2LPAR3 | |
| SCHEMBL3645476 | 0.87 | ENPP2 (0.57) | ENPP2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4667492-A2 | TARGETED LIPID PARTICLES FOR SYSTEMIC DELIVERY OF NUCLEIC ACID MOLECULES TO LEUKOCYTES | Ramot at Tel-Aviv University Ltd. (IL) | 2025-12-24 | — | — | EP | claimed |
| WO-2025242657-A1 | LIPOPEPTIDE BUILDING BLOCKS AND AGGREGATES | SHAPE BIOPHARMACEUTICALS AG (CH) | 2025-11-27 | — | — | WO | claimed |
| EP-4615416-A1 | SELF-ASSEMBLING LIPID NANOPARTICLES FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | Ramot at Tel-Aviv University Ltd. (IL) | 2025-09-17 | — | — | EP | claimed |
| EP-3160448-B1 | LIPOSOMAL FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | UNIV RAMOT (IL) | 2025-08-06 | — | — | EP | claimed |
| EP-3303598-B1 | TARGETED LIPID PARTICLES FOR SYSTEMIC DELIVERY OF NUCLEIC ACID MOLECULES TO LEUKOCYTES | UNIV RAMOT (IL) | 2025-03-19 | — | — | EP | claimed |
| WO-2025049765-A1 | TARGETING LIPID NANOPARTICLES FOR NUCLEIC ACID DELIVERY | EMD MILLIPORE CORPORATION (US) | 2025-03-06 | — | — | WO | claimed |
| WO-2025029640-A1 | TARGETING LIPOSOME FOR PROTEIN DEGRADER DELIVERY | SIGMA-ALDRICH CO. LLC (US) | 2025-02-06 | — | — | WO | claimed |
| US-12065664-B2 | Method for treatment of a leukocyte related disease by delivery of nucleic acid molecules to leukocytes using targeted lipid particles | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-08-20 | — | — | US | claimed |
| WO-2024100656-A1 | SELF-ASSEMBLING LIPID NANOPARTICLES FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-05-16 | — | — | WO | claimed |
| WO-2022103927-A1 | IMMUNOGENIC COMPOSITIONS FOR CORONAVIRUSES | SHAPE BIOPHARMACEUTICALS INC. (US) | 2022-05-19 | — | — | WO | claimed |
| US-20210108228-A1 | TARGETED LIPID PARTICLES FOR SYSTEMIC DELIVERY OF NUCLEIC ACID MOLECULES TO LEUKOCYTES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2021-04-15 | — | — | US | claimed |
| EP-2839015-B1 | LIPIDATED GLYCOSAMINOGLYCAN PARTICLES FOR THE DELIVERY OF NUCLEIC ACIDS | UNIV RAMOT (IL) | 2020-04-29 | — | — | EP | claimed |
| US-10583084-B2 | Liposomal formulations for delivery of nucleic acids | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2020-03-10 | — | — | US | claimed |
| US-20180142261-A1 | TARGETED LIPID PARTICLES FOR SYSTEMIC DELIVERY OF NUCLEIC ACID MOLECULES TO LEUKOCYTES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2018-05-24 | — | — | US | claimed |
| EP-3303598-A1 | TARGETED LIPID PARTICLES FOR SYSTEMIC DELIVERY OF NUCLEIC ACID MOLECULES TO LEUKOCYTES | Ramot at Tel-Aviv University Ltd. (IL) | 2018-04-11 | — | — | EP | claimed |
| US-20170128367-A1 | LIPOSOMAL FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2017-05-11 | — | — | US | claimed |
| EP-3160448-A1 | LIPOSOMAL FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | Ramot at Tel-Aviv University Ltd. (IL) | 2017-05-03 | — | — | EP | claimed |
| WO-2016189532-A1 | TARGETED LIPID PARTICLES FOR SYSTEMIC DELIVERY OF NUCLEIC ACID MOLECULES TO LEUKOCYTES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2016-12-01 | — | — | WO | claimed |
| WO-2015198326-A1 | LIPOSOMAL FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-12-30 | — | — | WO | claimed |
| US-20150140108-A1 | LIPIDATED GLYCOSAMINOGLYCAN PARTICLES FOR THE DELIVERY OF NUCLEIC ACIDS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-05-21 | — | — | US | claimed |